STOCK TITAN

AUNA S.A. (AUNA) SEC Filings

AUNA NYSE

Auna S.A.'s SEC filings document a foreign private issuer operating a healthcare services and health-plan platform in Mexico, Peru and Colombia. Current reports on Form 6-K furnish press releases, IFRS financial statements, operating KPIs, annual Form 20-F availability, and updates on healthcare services in Peru, Colombia and Mexico and Oncosalud Peru.

The filing record also covers capital-structure matters, including senior secured notes and completed debt refinancing, as well as material project and agreement disclosures related to the Torre Trecca public-private partnership. These documents frame Auna's results, leverage, segment activity and corporate reporting obligations under its NYSE-listed issuer structure.

Rhea-AI Summary

Auna S.A.’s subsidiary Grupo Salud Auna México, S.A. de C.V. (GSAM) transferred its hospital business to newly incorporated subsidiary Grupo Salud Auna México Hospitales, S.A. de C.V. (GSAMH) on October 27, 2026. GSAM continues to hold the insurance business, and both businesses remain under Auna’s ultimate ownership. Separate unaudited spin-off pro forma balance sheets as of September 30, 2026 show total assets of 14,118,224,925 Mexican pesos for GSAMH and 404,215,138 Mexican pesos for GSAM.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Auna S.A. (AUNA) announced a preliminary update to its full-year 2026 outlook. It expects revenue growth to be in line with guidance communicated early in the year, supported by a continued strong recovery in Mexico during the second half. Adjusted EBITDA is now expected to be broadly stable year over year, compared with growth contemplated in prior guidance.

On its second-quarter earnings call, Auna said that, excluding one-time effects primarily related to payor billing penalties associated with reconciliations of prior years’ receivables, full-year Adjusted EBITDA growth was expected at the lower end of the prior 10% to 14% FX-neutral guidance range. A specific payor contract in Colombia has added temporary cost pressure due to an unexpected high incidence of advanced-stage cancer cases in the covered population. Capital expenditures remain within previously communicated guidance of approximately 4.0% of consolidated revenue; free cash flow and leverage continue to evolve favorably. Auna will provide additional details on the contract’s implications for Adjusted EBITDA at its upcoming third-quarter 2026 earnings call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.02%
Tags
current report
-
Rhea-AI Summary

AUNA, S.A. shares are the subject of RWC Asset Management LLP’s amended ownership report, which lists 1,520,929 shares beneficially owned, equal to 5.046% of the class. RWC reported sole voting and dispositive power over 1,520,929 shares, with zero shared voting or dispositive power.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

AUNA S.A. (AUNA) reported 2Q26 results showing solid growth but weaker margins and earnings. Revenue rose 13% year over year to S/1,238 million (9% FX-neutral), with all three geographies (Mexico, Peru, Colombia) growing in local currency, led by Colombia’s 13% increase and Peru’s 8% gain.

Adjusted EBITDA declined 6% to S/227 million, and margin compressed to 18.4% from 22.1%, reflecting service mix, higher pharmacy, payroll and nursing costs, and accepted billing-related penalties in Peru. Net income dropped to S/33 million from 84 million, mainly due to a much smaller positive FX impact in finance costs; Adjusted Net Income fell to S/40 million from 89 million.

Cash generation was strong: year-to-date operating cash flow increased 76% to S/441 million, and free cash flow reached S/400 million versus 143 million a year earlier. Net debt declined to S/3,252 million and the leverage ratio remained at 3.6x, while management reaffirmed 2026 FX-neutral revenue growth guidance near 12% and expects Adjusted EBITDA growth at the low end of its 10–14% range, with capex around 4% of revenues.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
current report
-
Rhea-AI Summary

Teacher Retirement System of Texas filed an amended Schedule 13G reporting its passive ownership in AUNA S.A.. As of the close of business on April 14, 2026, it beneficially owned 1,504,140 Class A Ordinary Shares, with a par value of $0.01 per share. This position represents 4.99% of AUNA’s Class A Ordinary Shares outstanding, based on 30,095,388 shares outstanding as of December 31, 2025, as reported in AUNA’s Form 20-F. The fund reports sole voting and dispositive power over all 1,504,140 shares and no shared voting or dispositive power, and notes that it now holds 5 percent or less of this class.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Auna S.A. reported preliminary key performance indicators for the second quarter ended June 30, 2026 across its healthcare operations in Mexico, Peru and Colombia. Metrics include emergency treatments, surgeries, days hospitalized, chemotherapies and radiotherapies, plan memberships and protected lives under risk-sharing agreements.

In 2Q 2026, Healthcare Services Peru recorded 51,769 emergency treatments and capacity utilization of 80.2%, while Healthcare Services Colombia reported 3,143,694 protected lives and capacity utilization of 79.2%. As of June 30, 2026, Auna operated 31 facilities with 2,337 beds and 1.4 million health plan members. These indicators are preliminary and subject to revision.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.98%
Tags
current report
Rhea-AI Summary

RWC Asset Management LLP reported beneficial ownership of 1,520,929 shares of AUNA, S.A., representing 5.05% of the class as of 06/30/2026. The filing is an amended Schedule 13G/A (Amendment No. 8) and shows RWC holds sole voting and dispositive power over the reported shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Auna S.A. reported the results of its annual general meeting, where shareholders approved all matters presented to them. The company also updated its board structure, setting the board at seven members after Jorge Basadre and Guadalupe Phillips stepped down, with the vacancies not being filled for now. Following these changes, the board still has a majority of independent directors. As of March 31, 2026, Auna’s Latin American healthcare platform included 31 facilities with 2,337 beds and 1.4 million health plan members.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

AUNA S.A.’s president and director Jesus Zamora León reported open-market purchases of 51,454 Class A Common Shares between May 20 and May 29, 2026, at prices between $4.15 and $4.39 per share.

Following these transactions, he holds 69,130 Class A shares directly and 55,134 Class A shares indirectly through Enfoca Ltd. He is also indirectly associated with 32,029,016 Class B common shares held by the Enfoca Entities, each convertible into one Class A share under the issuer’s articles. The filing notes it was inadvertently filed late due to an administrative error.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

AUNA S.A. director Wilton John sold 17,574 Class A Common Shares in an open-market transaction. The weighted average sale price was $4.1711 per share, with individual trades between $4.1700 and $4.2001. Following the sale, he directly owns 49,974 Class A Common Shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many AUNA S.A. (AUNA) SEC filings are available on StockTitan?

StockTitan tracks 70 SEC filings for AUNA S.A. (AUNA), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for AUNA S.A. (AUNA)?

The most recent SEC filing for AUNA S.A. (AUNA) was filed on October 28, 2026.